Results 41 to 50 of about 1,523,177 (283)

Applying multi-criteria decision analysis to prioritise age-friendly criteria for policy implications

open access: yesInternational Journal of Urban Sustainable Development, 2023
Significant increase in the proportion of elderly and its expected further increase in the days to come draw attention of policymakers, practitioners, and researchers to enhance a community’s age-friendliness.
Sashi Bhusan Raut
doaj   +1 more source

Organic farming and multicriteria decisions: An economic survey [PDF]

open access: yes, 2012
Organic food production is a sphere where decision making is multi-facetted and complex. This applies to producers, political decision makers and consumers alike.
Christensen, Tove   +3 more
core  

Biodiesel from microalgae : the use of multi-criteria decision analysis for strain selection [PDF]

open access: yes, 2015
Microalgae strain selection is a vital step in the production of biodiesel from microalgae. In this study, Multi-Criteria Decision Analysis (MCDA) methodologies are adopted to resolve this problem. The aim of this study is to identify the best microalgae
Nwokoagbara, Ezinne   +2 more
core   +1 more source

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

open access: yesMolecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan   +9 more
wiley   +1 more source

Validating a Multi-criteria decision analysis (MCDA) framework for health care decision making (abstract) [PDF]

open access: yes, 2011
OBJECTIVES: When evaluating healthcare interventions, decision-makers are increasingly asked to consider multiple criteria to support their decision. The MCDA-based EVIDEM framework was developed to support this process.
Dolan, J.G.   +4 more
core   +1 more source

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

open access: yesMolecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker   +16 more
wiley   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

open access: yesMolecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard   +12 more
wiley   +1 more source

Professor Assessment Using Multi-Criteria Decision Analysis

open access: yesProcedia Computer Science, 2015
AbstractThis paper presents results from the pilot project on teacher assessment of the Regional University of Blumenau. It contains discussions about the project was elaborated by the team of internal assessments of the university, discussing the dimensions, issues and quantitative analysis techniques and the construction of the FURB Professoŕs ...
Hein, Nelson   +2 more
openaire   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

open access: yesMolecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj   +4 more
wiley   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy